Pathogenicity and virulence of Mycobacterium tuberculosis

References

• Pai M, Behr MA, Dowdy D, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report 2021. 2021.
   Google Scholar
• Bourzac K. Infectious disease: beating the big three. Nature. 2014;507:S4–29.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Tuberculosis. 2021.
   Google Scholar
• Cohen A, Mathiasen VD, Schon T, et al. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54:1900655.
   PubMed Web of Science ®Google Scholar
• Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLOS Med. 2016;13:e1002152.
   PubMed Web of Science ®Google Scholar
• Chee CBE, Reves R, Zhang Y, et al. Latent tuberculosis infection: opportunities and challenges. Respirology. 2018;23:893–900.
   PubMed Web of Science ®Google Scholar
• Gong W, Wu X. Differential diagnosis of latent tuberculosis infection and active tuberculosis: a key to a successful tuberculosis control strategy. Front Microbiol. 2021;12:745592.
   PubMed Web of Science ®Google Scholar
• Fatima S, Kumari A, Das G, et al. Tuberculosis vaccine: a journey from BCG to present. Life Sci. 2020;252:117594.
   PubMed Web of Science ®Google Scholar
• Dockrell HM, Smith SG. What have we learnt about BCG vaccination in the last 20 years? Front Immunol. 2017;8:1134.
   PubMed Web of Science ®Google Scholar
• Darrah PA, Zeppa JJ, Maiello P, et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature. 2020;577:95–102.
   PubMed Web of Science ®Google Scholar
• Irvine EB, O’Neil A, Darrah PA, et al. Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques. Nat Immunol. 2021;22:1515–1523.
   PubMed Web of Science ®Google Scholar
• Pai M, Behr M. Latent mycobacterium tuberculosis infection and interferon-gamma release assays. Microbiol Spectr. 2016;4. DOI:10.1128/microbiolspec.TBTB2-0023-2016
   Web of Science ®Google Scholar
• McShane H. Tuberculosis vaccines: beyond bacille Calmette-Guerin. Philos Trans R Soc Lond B Biol Sci. 2011;366:2782–2789.
   PubMed Web of Science ®Google Scholar
• Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192–1204.
   PubMed Web of Science ®Google Scholar
• Takwoingi Y, Whitworth H, Rees-Roberts M, et al. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation. Health Technol Assess. 2019;23:1–152.
   PubMed Web of Science ®Google Scholar
• Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27:3–20.
   PubMed Web of Science ®Google Scholar
• Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, et al. Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol. 2020;11:2006.
   PubMed Web of Science ®Google Scholar
• Munoz L, Stagg HR, Abubakar I. Diagnosis and management of latent tuberculosis infection: table 1. Cold Spring Harb Perspect Med. 2015;5:a017830.
   PubMed Web of Science ®Google Scholar
• Huaman MA, Sterling TR. Treatment of latent tuberculosis infection-an update. Clin Chest Med. 2019;40:839–848.
   PubMed Web of Science ®Google Scholar
• Marx FM, Cohen T, Menzies NA, et al. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. Lancet Glob Health. 2020;8:e1223–33.
   PubMed Web of Science ®Google Scholar
• Dela Cruz CS, Lyons PG, Pasnick S, et al. Treatment of drug-susceptible tuberculosis. Ann Am Thorac Soc. 2016;13:2060–2063.
   PubMed Web of Science ®Google Scholar
• Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147–95.
   PubMed Web of Science ®Google Scholar
• Peloquin CA, Davies GR. The treatment of tuberculosis. Clin Pharmacol Ther. 2021;110:1455–1466.
   PubMed Web of Science ®Google Scholar
• Ramachandran G, Swaminathan S. Safety and tolerability profile of second-line anti-tuberculosis medications. Drug Saf. 2015;38:253–269.
   PubMed Web of Science ®Google Scholar
• Quenard F, Fournier PE, Drancourt M, et al. Role of second-line injectable antituberculosis drugs in the treatment of MDR/XDR tuberculosis. Int J Antimicrob Agents. 2017;50:252–254.
   PubMed Web of Science ®Google Scholar
• Heym B, Alzari PM, Honore N, et al. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol. 1995;15:235–245.
   PubMed Web of Science ®Google Scholar
• Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993;341:647–650.
   PubMed Web of Science ®Google Scholar
• Scorpio A, Lindholm-Levy P, Heifets L, et al. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1997;41:540–543.
   PubMed Web of Science ®Google Scholar
• Parsons LM, Salfinger M, Clobridge A, et al. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother. 2005;49:2218–2225.
   PubMed Web of Science ®Google Scholar
• Conradie F, Diacon AH, Ngubane N, et al. Treatment of highly drug-resistant pulmonary tuberculosis. N Engl J Med. 2020;382:893–902.
   PubMed Web of Science ®Google Scholar
• Joshi SM, Pandey AK, Capite N, et al. Characterization of mycobacterial virulence genes through genetic interaction mapping. Proc Natl Acad Sci U S A. 2006;103:11760–11765.
   PubMed Web of Science ®Google Scholar
• Smith CM, Baker RE, Proulx MK, et al. Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice. Elife. 2022;11. DOI:10.7554/eLife.74419.
   Web of Science ®Google Scholar
• Sassetti CM, Rubin EJ. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A. 2003;100:12989–12994.
   PubMed Web of Science ®Google Scholar
• Comas I, Coscolla M, Luo T, et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet. 2013;45:1176–1182.
   PubMed Web of Science ®Google Scholar
• Coscolla M, Gagneux S, Menardo F, et al. Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history. Microb Genom. 2021;7. DOI:10.1099/mgen.0.000477.
   Web of Science ®Google Scholar
• Coll F, McNerney R, Guerra-Assuncao JA, et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun. 2014;5:4812.
   PubMed Web of Science ®Google Scholar
• Cardona PJ, Catala M, Prats C. Origin of tuberculosis in the Paleolithic predicts unprecedented population growth and female resistance. Sci Rep. 2020;10:42.
   PubMed Web of Science ®Google Scholar
• Moller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis (Edinb). 2010;90:71–83.
   PubMed Web of Science ®Google Scholar
• Portevin D, Gagneux S, Comas I, et al. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLOS Pathog. 2011;7:e1001307.
   PubMed Web of Science ®Google Scholar
• Napier G, Campino S, Merid Y, et al. Robust barcoding and identification of Mycobacterium tuberculosis lineages for epidemiological and clinical studies. Genome Med. 2020;12:114.
   PubMed Web of Science ®Google Scholar
• Rodrigues TS, Conti BJ, Fraga-Silva TFC, et al. Interplay between alveolar epithelial and dendritic cells and Mycobacterium tuberculosis. J Leukocyte Biol. 2020;108:1139–1156.
   PubMed Web of Science ®Google Scholar
• Khan HS, Nair VR, Ruhl CR, et al. Identification of scavenger receptor B1 as the airway microfold cell receptor for Mycobacterium tuberculosis. Elife. 2020;9. DOI:10.7554/eLife.52551.
   Web of Science ®Google Scholar
• Nair VR, Franco LH, Zacharia VM, et al. Microfold cells actively translocate mycobacterium tuberculosis to initiate infection. Cell Rep. 2016;16:1253–1258.
   PubMed Web of Science ®Google Scholar
• Killick KE, Ni Cheallaigh C, O’Farrelly C, et al. Receptor-mediated recognition of mycobacterial pathogens. Cell Microbiol. 2013;15:1484–1495.
   PubMed Web of Science ®Google Scholar
• Cohen SB, Gern BH, Delahaye JL, et al. Alveolar macrophages provide an early mycobacterium tuberculosis niche and initiate dissemination. Cell Host Microbe. 2018;24:439–46 e4.
   PubMed Web of Science ®Google Scholar
• Bermudez LE, Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun. 1996;64:1400–1406.
   PubMed Web of Science ®Google Scholar
• Hernandez-Pando R, Jeyanathan M, Mengistu G, et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet. 2000;356:2133–2138.
   PubMed Web of Science ®Google Scholar
• Danelishvili L, McGarvey J, Li YJ, et al. Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol. 2003;5:649–660.
   PubMed Web of Science ®Google Scholar
• Lovey A, Verma S, Kaipilyawar V, et al. Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains. Nat Commun. 2022;13:884.
   PubMed Web of Science ®Google Scholar
• Urdahl KB, Shafiani S, Ernst JD. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol. 2011;4:288–293.
   PubMed Web of Science ®Google Scholar
• Shaler CR, Horvath C, Lai R, et al. Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis. Clin Dev Immunol. 2012;2012:628293.
   PubMedGoogle Scholar
• Carpenter SM, Lu LL. Leveraging antibody, B cell and Fc receptor interactions to understand heterogeneous immune responses in tuberculosis. Front Immunol. 2022;13:830482.
   PubMed Web of Science ®Google Scholar
• Cronan MR. In the thick of it: formation of the tuberculous granuloma and its effects on host and therapeutic responses. Front Immunol. 2022;13:820134.
   PubMed Web of Science ®Google Scholar
• Cohen SB, Gern BH, Urdahl KB. The tuberculous granuloma and preexisting immunity. Annu Rev Immunol. 2022;40:589–614.
   PubMed Web of Science ®Google Scholar
• Park HD, Guinn KM, Harrell MI, et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol. 2003;48:833–843.
   PubMed Web of Science ®Google Scholar
• Behr MA, Kaufmann E, Duffin J, et al. Latent tuberculosis: two centuries of confusion. Am J Respir Crit Care Med. 2021;204:142–148.
   PubMed Web of Science ®Google Scholar
• Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ. 2019;367:l5770.
   PubMedGoogle Scholar
• Zumla A, Raviglione M, Hafner R, et al. Tuberculosis. N Engl J Med. 2013;368:745–755.
   PubMed Web of Science ®Google Scholar
• Lerner TR, Queval CJ, Lai RP, et al. Mycobacterium tuberculosis cords within lymphatic endothelial cells to evade host immunity. JCI Insight. 2020;5. DOI:10.1172/jci.insight.136937.
   Web of Science ®Google Scholar
• Barr DA, Schutz C, Balfour A, et al. Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis. EBioMedicine. 2022;78:103949.
   PubMed Web of Science ®Google Scholar
• Ong CW, Elkington PT, Brilha S, et al. Neutrophil-Derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis. PLOS Pathog. 2015;11:e1004917.
   PubMed Web of Science ®Google Scholar
• Ruhl CR, Pasko BL, Khan HS, et al. Mycobacterium tuberculosis Sulfolipid-1 activates nociceptive neurons and induces cough. Cell. 2020;181:293–305 e11.
   PubMed Web of Science ®Google Scholar
• Shiloh MU. Mechanisms of mycobacterial transmission: how does Mycobacterium tuberculosis enter and escape from the human host. Future Microbiol. 2016;11:1503–1506.
   PubMed Web of Science ®Google Scholar
• Haas MK, Belknap RW. Updates in the treatment of active and latent tuberculosis. Semin Respir Crit Care Med. 2018;39:297–309.
   PubMed Web of Science ®Google Scholar
• Kock R, Michel AL, Yeboah-Manu D, et al. Zoonotic tuberculosis - the changing landscape. Int J Infect Dis. 2021;113 Suppl 1:S68–72.
   PubMed Web of Science ®Google Scholar
• Zuber B, Chami M, Houssin C, et al. Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J Bacteriol. 2008;190:5672–5680.
   PubMed Web of Science ®Google Scholar
• Peterson EJ, Bailo R, Rothchild AC, et al. Path-seq identifies an essential mycolate remodeling program for mycobacterial host adaptation. Mol Syst Biol. 2019;15:e8584.
   PubMed Web of Science ®Google Scholar
• Batt SM, Minnikin DE, Besra GS. The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host’s immune system. Biochem J. 2020;477:1983–2006.
   PubMed Web of Science ®Google Scholar
• Rahlwes KC, Sparks IL, Morita YS. Cell walls and membranes of actinobacteria. Subcell Biochem. 2019;92:417–469.
   PubMedGoogle Scholar
• Dulberger CL, Rubin EJ, Boutte CC. The mycobacterial cell envelope - a moving target. Nat Rev Microbiol. 2020;18:47–59.
   PubMed Web of Science ®Google Scholar
• Jackson M, Stevens CM, Zhang L, et al. Transporters involved in the biogenesis and functionalization of the mycobacterial cell envelope. Chem Rev. 2021;121:5124–5157.
   PubMed Web of Science ®Google Scholar
• Zamyatina A, Heine H. Lipopolysaccharide recognition in the crossroads of TLR4 and Caspase-4/11 mediated inflammatory pathways. Front Immunol. 2020;11:585146.
   PubMed Web of Science ®Google Scholar
• Layre E. Trafficking of mycobacterium tuberculosis envelope components and release within extracellular vesicles: host-pathogen interactions beyond the wall. Front Immunol. 2020;11:1230.
   PubMedGoogle Scholar
• Augenstreich J, Briken V. Host cell targets of released lipid and secreted protein effectors of mycobacterium tuberculosis. Front Cell Infect Microbiol. 2020;10:595029.
   PubMed Web of Science ®Google Scholar
• Prados-Rosales R, Carreno LJ, Batista-Gonzalez A, et al. Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis. MBio. 2014;5: e01921-14. DOI:10.1128/mBio.01921-14.
   PubMed Web of Science ®Google Scholar
• Siegrist MS, Bertozzi CR. Mycobacterial lipid logic. Cell Host Microbe. 2014;15:1–2.
   PubMed Web of Science ®Google Scholar
• Rens C, Chao JD, Sexton DL, et al. Roles for phthiocerol dimycocerosate lipids in Mycobacterium tuberculosis pathogenesis. Microbiology (Reading). 2021;167. DOI:10.1099/mic.0.001042
   PubMed Web of Science ®Google Scholar
• Sequeira PC, Senaratne RH, Riley LW. Inhibition of toll-like receptor 2 (TLR-2)-mediated response in human alveolar epithelial cells by mycolic acids and Mycobacterium tuberculosis mce1 operon mutant. Pathog Dis. 2014;70:132–140.
   PubMed Web of Science ®Google Scholar
• Iizasa E, Chuma Y, Uematsu T, et al. TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation. Nat Commun. 2021;12:2299.
   PubMed Web of Science ®Google Scholar
• Sharma NK, Rathor N, Sinha R, et al. Expression of mycolic acid in response to stress and association with differential clinical manifestations of tuberculosis. Int J Mycobacteriol. 2019;8:237–243.
   PubMed Web of Science ®Google Scholar
• Buter J, Cheng TY, Ghanem M, et al. Mycobacterium tuberculosis releases an antacid that remodels phagosomes. Nat Chem Biol. 2019;15:889–899.
   PubMed Web of Science ®Google Scholar
• Ghanem M, Dube JY, Wang J, et al. Heterologous production of 1-Tuberculosinyladenosine in mycobacterium kansasii models pathoevolution towards the transcellular lifestyle of mycobacterium tuberculosis. MBio. 2020;11. DOI:10.1128/mBio.02645-20.
   PubMed Web of Science ®Google Scholar
• Buter J, Heijnen D, Wan IC, et al. Stereoselective synthesis of 1-tuberculosinyl adenosine; a virulence factor of mycobacterium tuberculosis. J Org Chem. 2016;81:6686–6696.
   PubMed Web of Science ®Google Scholar
• Sinsimer D, Huet G, Manca C, et al. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun. 2008;76:3027–3036.
   PubMed Web of Science ®Google Scholar
• Constant P, Perez E, Malaga W, et al. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem. 2002;277:38148–38158.
   PubMed Web of Science ®Google Scholar
• Reed MB, Domenech P, Manca C, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature. 2004;431:84–87.
   PubMed Web of Science ®Google Scholar
• Dagur PK, Sharma B, Upadhyay R, et al. Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate TCR- and CD28-triggered proximal biochemical events, leading to T-cell unresponsiveness in mycobacterial diseases. Lipids Health Dis. 2012;11:119.
   PubMed Web of Science ®Google Scholar
• Mishra M, Adhyapak P, Dadhich R, et al. Dynamic remodeling of the host cell membrane by virulent mycobacterial sulfoglycolipid-1. Sci Rep. 2019;9:12844.
   PubMed Web of Science ®Google Scholar
• Patin EC, Geffken AC, Willcocks S, et al. Trehalose dimycolate interferes with FcgammaR-mediated phagosome maturation through Mincle, SHP-1 and FcgammaRIIB signalling. PLoS ONE. 2017;12:e0174973.
   PubMed Web of Science ®Google Scholar
• Bowker N, Salie M, Schurz H, et al. Polymorphisms in the pattern recognition receptor mincle gene (CLEC4E) and association with tuberculosis. Lung. 2016;194:763–767.
   PubMed Web of Science ®Google Scholar
• Huber A, Kallerup RS, Korsholm KS, et al. Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivo. Innate Immun. 2016;22:405–418.
   PubMed Web of Science ®Google Scholar
• Ishikawa E, Ishikawa T, Morita YS, et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med. 2009;206:2879–2888.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Toyonaga K, Mori D, et al. C-type lectin MCL is an FcRgamma-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor. Immunity. 2013;38:1050–1062.
   PubMed Web of Science ®Google Scholar
• Walton EM, Cronan MR, Cambier CJ, et al. Cyclopropane modification of trehalose dimycolate drives granuloma angiogenesis and mycobacterial growth through VEGF signaling. Cell Host Microbe. 2018;24:514–25 e6.
   PubMed Web of Science ®Google Scholar
• Feinberg H, Jegouzo SA, Rowntree TJ, et al. Mechanism for recognition of an unusual mycobacterial glycolipid by the macrophage receptor mincle. J Biol Chem. 2013;288:28457–28465.
   PubMed Web of Science ®Google Scholar
• Feinberg H, Rambaruth ND, Jegouzo SA, et al. Binding sites for acylated trehalose analogs of glycolipid ligands on an extended carbohydrate recognition domain of the macrophage receptor mincle. J Biol Chem. 2016;291:21222–21233.
   PubMed Web of Science ®Google Scholar
• Furukawa A, Kamishikiryo J, Mori D, et al. Structural analysis for glycolipid recognition by the C-type lectins Mincle and MCL. Proc Natl Acad Sci U S A. 2013;110:17438–17443.
   PubMed Web of Science ®Google Scholar
• Doz E, Rose S, Nigou J, et al. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J Biol Chem. 2007;282:26014–26025.
   PubMed Web of Science ®Google Scholar
• Puissegur MP, Lay G, Gilleron M, et al. Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and beta 1 integrin-mediated pathway. J Immunol. 2007;178:3161–3169.
   PubMed Web of Science ®Google Scholar
• Kalscheuer R, Palacios A, Anso I, et al. The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis. Biochem J. 2019;476:1995–2016.
   PubMed Web of Science ®Google Scholar
• Yuan C, Qu ZL, Tang XL, et al. Mycobacterium tuberculosis mannose-capped lipoarabinomannan induces IL-10-producing B cells and hinders CD4(+)Th1 immunity. iScience. 2019;11:13–30.
   PubMed Web of Science ®Google Scholar
• Maeda N, Nigou J, Herrmann JL, et al. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem. 2003;278:5513–5516.
   PubMed Web of Science ®Google Scholar
• Stoop EJ, Mishra AK, Driessen NN, et al. Mannan core branching of lipo(arabino)mannan is required for mycobacterial virulence in the context of innate immunity. Cell Microbiol. 2013;15:2093–2108.
   PubMed Web of Science ®Google Scholar
• Toyonaga K, Torigoe S, Motomura Y, et al. C-Type lectin receptor DCAR recognizes mycobacterial phosphatidyl-inositol mannosides to promote a Th1 response during infection. Immunity. 2016;45:1245–1257.
   PubMed Web of Science ®Google Scholar
• Lugo-Villarino G, Troegeler A, Balboa L, et al. The C-Type lectin receptor DC-SIGN has an anti-inflammatory role in human M(IL-4) macrophages in response to mycobacterium tuberculosis. Front Immunol. 2018;9:1123.
   PubMed Web of Science ®Google Scholar
• Driessen NN, Ummels R, Maaskant JJ, et al. Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN. Infect Immun. 2009;77:4538–4547.
   PubMed Web of Science ®Google Scholar
• Doz E, Rose S, Court N, et al. Mycobacterial phosphatidylinositol mannosides negatively regulate host Toll-like receptor 4, MyD88-dependent proinflammatory cytokines, and TRIF-dependent co-stimulatory molecule expression. J Biol Chem. 2009;284:23187–23196.
   PubMed Web of Science ®Google Scholar
• Torrelles JB, Azad AK, Schlesinger LS. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J Immunol. 2006;177:1805–1816.
   PubMed Web of Science ®Google Scholar
• Reijneveld JF, Holzheimer M, Young DC, et al. Synthetic mycobacterial diacyl trehaloses reveal differential recognition by human T cell receptors and the C-type lectin Mincle. Sci Rep. 2021;11:1.
   PubMed Web of Science ®Google Scholar
• Holzheimer M, Reijneveld JF, Ramnarine AK, et al. Asymmetric total synthesis of mycobacterial diacyl trehaloses demonstrates a role for lipid structure in immunogenicity. ACS Chem Biol. 2020;15:1835–1841.
   PubMed Web of Science ®Google Scholar
• Daffe M, Lacave C, Laneelle MA, et al. Polyphthienoyl trehalose, glycolipids specific for virulent strains of the tubercle bacillus. Eur J Biochem. 1988;172:579–584.
   PubMedGoogle Scholar
• Decout A, Silva-Gomes S, Drocourt D, et al. Rational design of adjuvants targeting the C-type lectin Mincle. Proc Natl Acad Sci U S A. 2017;114:2675–2680.
   PubMed Web of Science ®Google Scholar
• Glatman-Freedman A, Casadevall A, Dai Z, et al. Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. J Clin Microbiol. 2004;42:3225–3231.
   PubMed Web of Science ®Google Scholar
• Kang PB, Azad AK, Torrelles JB, et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med. 2005;202:987–999.
   PubMed Web of Science ®Google Scholar
• Rajaram MVS, Arnett E, Azad AK, et al. M. tuberculosis-initiated human mannose receptor signaling regulates macrophage recognition and vesicle trafficking by FcRgamma-Chain, Grb2, and SHP-1. Cell Rep. 2017;21:126–140.
   PubMed Web of Science ®Google Scholar
• Taylor ME, Drickamer K. Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. J Biol Chem. 1993;268:399–404.
   PubMed Web of Science ®Google Scholar
• Ishida E, Corrigan DT, Malonis RJ, et al. Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopes. Commun Biol. 2021;4:1181.
   PubMed Web of Science ®Google Scholar
• Koliwer-Brandl H, Syson K, van de Weerd R, et al. Metabolic network for the biosynthesis of intra- and extracellular alpha-glucans required for virulence of mycobacterium tuberculosis. PLOS Pathog. 2016;12:e1005768.
   PubMed Web of Science ®Google Scholar
• Geurtsen J, Chedammi S, Mesters J, et al. Identification of mycobacterial alpha-glucan as a novel ligand for DC-SIGN: involvement of mycobacterial capsular polysaccharides in host immune modulation. J Immunol. 2009;183:5221–5231.
   PubMed Web of Science ®Google Scholar
• Agrawal P, Gupta P, Swaminathan K, et al. Alpha-Glucan pathway as a novel Mtb drug target: structural insights and cues for polypharmcological targeting of GlgB and GlgE. Curr Med Chem. 2014;21:4074–4084.
   PubMed Web of Science ®Google Scholar
• Wassermann R, Gulen MF, Sala C, et al. Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1. Cell Host Microbe. 2015;17:799–810.
   PubMed Web of Science ®Google Scholar
• Watson RO, Bell SL, MacDuff DA, et al. The cytosolic sensor cGAS detects mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy. Cell Host Microbe. 2015;17:811–819.
   PubMed Web of Science ®Google Scholar
• Watson RO, Manzanillo PS, Cox JS. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell. 2012;150:803–815.
   PubMed Web of Science ®Google Scholar
• Collins AC, Cai H, Li T, et al. Cyclic GMP-AMP synthase is an innate immune DNA sensor for mycobacterium tuberculosis. Cell Host Microbe. 2015;17:820–828.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Schorey JS. Mycobacterium tuberculosis-induced IFN-beta production requires cytosolic DNA and RNA sensing pathways. J Exp Med. 2018;215:2919–2935.
   PubMed Web of Science ®Google Scholar
• Chang DPS, Guan XL. Metabolic versatility of mycobacterium tuberculosis during infection and dormancy. Metabolites. 2021;11:11.
   Web of Science ®Google Scholar
• Ehrt S, Schnappinger D, Rhee KY. Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis. Nat Rev Microbiol. 2018;16:496–507.
   PubMed Web of Science ®Google Scholar
• Eoh H, Wang Z, Layre E, et al. Metabolic anticipation in Mycobacterium tuberculosis. Nat Microbiol. 2017;2:17084.
   PubMed Web of Science ®Google Scholar
• Fineran P, Lloyd-Evans E, Lack NA, et al. Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway. Wellcome Open Res. 2016;1:18.
   PubMedGoogle Scholar
• Baek SH, Li AH, Sassetti CM. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol. 2011;9:e1001065.
   PubMed Web of Science ®Google Scholar
• Lau SK, Lam CW, Curreem SO, et al. Identification of specific metabolites in culture supernatant of Mycobacterium tuberculosis using metabolomics: exploration of potential biomarkers. Emerg Microbes Infect. 2015;4:e6.
   PubMed Web of Science ®Google Scholar
• Collins JM, Walker DI, Jones DP, et al. High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans. PLoS ONE. 2018;13:e0205398.
   PubMed Web of Science ®Google Scholar
• Bansal-Mutalik R, Nikaido H. Mycobacterial outer membrane is a lipid bilayer and the inner membrane is unusually rich in diacyl phosphatidylinositol dimannosides. Proc Natl Acad Sci U S A. 2014;111:4958–4963.
   PubMed Web of Science ®Google Scholar
• Ojha AK, Baughn AD, Sambandan D, et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol. 2008;69:164–174.
   PubMed Web of Science ®Google Scholar
• Flores-Villanueva PO, Ruiz-Morales JA, Song CH, et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med. 2005;202:1649–1658.
   PubMed Web of Science ®Google Scholar
• Moopanar K, Mvubu NE. Lineage-specific differences in lipid metabolism and its impact on clinical strains of Mycobacterium tuberculosis. Microb Pathog. 2020;146:104250.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Naka T, Doi T, et al. Direct molecular mass determination of trehalose monomycolate from 11 species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology (Reading). 2005;151:1443–1452.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Naka T, McNeil MR, et al. Intact molecular characterization of cord factor (trehalose 6,6’-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology (Reading). 2005;151:3403–3416.
   PubMed Web of Science ®Google Scholar
• Matsunaga I, Moody DB. Mincle is a long sought receptor for mycobacterial cord factor. J Exp Med. 2009;206:2865–2868.
   PubMed Web of Science ®Google Scholar
• Lee WB, Kang JS, Yan JJ, et al. Neutrophils promote mycobacterial trehalose dimycolate-induced lung inflammation via the mincle pathway. PLOS Pathog. 2012;8:e1002614.
   PubMed Web of Science ®Google Scholar
• Hansen M, Peltier J, Killy B, et al. Macrophage phosphoproteome analysis reveals MINCLE-dependent and -independent mycobacterial cord factor signaling. Mol Cell Proteomics. 2019;18:669–685.
   PubMed Web of Science ®Google Scholar
• Wells CA, Salvage-Jones JA, Li X, et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol. 2008;180:7404–7413.
   PubMed Web of Science ®Google Scholar
• Rao V, Fujiwara N, Porcelli SA, et al. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med. 2005;201:535–543.
   PubMed Web of Science ®Google Scholar
• Rao V, Gao F, Chen B, et al. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. J Clin Invest. 2006;116:1660–1667.
   PubMed Web of Science ®Google Scholar
• Cambier CJ, Takaki KK, Larson RP, et al. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature. 2014;505:218–222.
   PubMed Web of Science ®Google Scholar
• Day TA, Mittler JE, Nixon MR, et al. Mycobacterium tuberculosis strains lacking surface lipid phthiocerol dimycocerosate are susceptible to killing by an early innate host response. Infect Immun. 2014;82:5214–5222.
   PubMed Web of Science ®Google Scholar
• Augenstreich J, Arbues A, Simeone R, et al. ESX-1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis. Cell Microbiol. 2017;19:e12726.
   Web of Science ®Google Scholar
• Astarie-Dequeker C, Le Guyader L, Malaga W, et al. Phthiocerol dimycocerosates of M. tuberculosis participate in macrophage invasion by inducing changes in the organization of plasma membrane lipids. PLOS Pathog. 2009;5:e1000289.
   PubMed Web of Science ®Google Scholar
• Bah A, Sanicas M, Nigou J, et al. The lipid virulence factors of mycobacterium tuberculosis exert multilayered control over autophagy-related pathways in infected human macrophages. Cells. 2020;9:666.
   PubMed Web of Science ®Google Scholar
• Quigley J, Hughitt VK, Velikovsky CA, et al. The cell wall lipid PDIM contributes to phagosomal escape and host cell exit of mycobacterium tuberculosis. MBio. 2017;8. DOI:10.1128/mBio.00148-17
   PubMed Web of Science ®Google Scholar
• Barnes DD, Lundahl MLE, Lavelle EC, et al. The emergence of phenolic glycans as virulence factors in mycobacterium tuberculosis. ACS Chem Biol. 2017;12:1969–1979.
   PubMed Web of Science ®Google Scholar
• Brites D, Gagneux S. The nature and evolution of genomic diversity in the mycobacterium tuberculosis complex. Adv Exp Med Biol. 2017;1019:1–26.
   PubMed Web of Science ®Google Scholar
• Gagneux S. Host-pathogen coevolution in human tuberculosis. Philos Trans R Soc Lond B Biol Sci. 2012;367:850–859.
   PubMed Web of Science ®Google Scholar
• Carey AF, Wang X, Cicchetti N, et al. Multiplexed strain phenotyping defines consequences of genetic diversity in mycobacterium tuberculosis for infection and vaccination outcomes. mSystems. 2022;7:e0011022.
   PubMed Web of Science ®Google Scholar
• Cambier CJ, O’Leary SM, O’Sullivan MP, et al. Phenolic glycolipid facilitates mycobacterial escape from microbicidal tissue-resident macrophages. Immunity. 2017;47:552–65 e4.
   PubMed Web of Science ®Google Scholar
• Dunlap MD, Howard N, Das S, et al. A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis. Mucosal Immunol. 2018;11:1727–1742.
   PubMed Web of Science ®Google Scholar
• Elsaidi HR, Lowary TL. Inhibition of cytokine release by mycobacterium tuberculosis phenolic glycolipid analogues. Chembiochem. 2014;15:1176–1182.
   PubMed Web of Science ®Google Scholar
• Purdy GE, Hsu FF. Complete characterization of polyacyltrehaloses from mycobacterium tuberculosis H37Rv biofilm cultures by multiple-stage linear ion-trap mass spectrometry reveals a new tetraacyltrehalose family. Biochemistry. 2021;60:381–397.
   PubMed Web of Science ®Google Scholar
• Magallanes-Puebla A, Espinosa-Cueto P, Lopez-Marin LM, et al. Mycobacterial glycolipid Di-O-acyl trehalose promotes a tolerogenic profile in dendritic cells. PLoS ONE. 2018;13:e0207202.
   PubMed Web of Science ®Google Scholar
• Espinosa-Cueto P, Escalera-Zamudio M, Magallanes-Puebla A, et al. Mycobacterial glycolipids di-O-acylated trehalose and tri-O-acylated trehalose downregulate inducible nitric oxide synthase and nitric oxide production in macrophages. BMC Immunol. 2015;16:38.
   PubMed Web of Science ®Google Scholar
• Passemar C, Arbues A, Malaga W, et al. Multiple deletions in the polyketide synthase gene repertoire of Mycobacterium tuberculosis reveal functional overlap of cell envelope lipids in host-pathogen interactions. Cell Microbiol. 2014;16:195–213.
   PubMed Web of Science ®Google Scholar
• Rousseau C, Neyrolles O, Bordat Y, et al. Deficiency in mycolipenate- and mycosanoate-derived acyltrehaloses enhances early interactions of Mycobacterium tuberculosis with host cells. Cell Microbiol. 2003;5:405–415.
   PubMed Web of Science ®Google Scholar
• Palma-Nicolas JP, Hernandez-Pando R, Segura E, et al. Mycobacterial di-O-acyl trehalose inhibits Th-1 cytokine gene expression in murine cells by down-modulation of MAPK signaling. Immunobiology. 2010;215:143–152.
   PubMed Web of Science ®Google Scholar
• Saavedra R, Segura E, Leyva R, et al. Mycobacterial di-O-acyl-trehalose inhibits mitogen- and antigen-induced proliferation of murine T cells in vitro. Clin Diagn Lab Immunol. 2001;8:1081–1088.
   PubMedGoogle Scholar
• Goren MB. Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. I. Purification and properties. Biochim Biophys Acta. 1970;210:116–126.
   PubMedGoogle Scholar
• Gilmore SA, Schelle MW, Holsclaw CM, et al. Sulfolipid-1 biosynthesis restricts Mycobacterium tuberculosis growth in human macrophages. ACS Chem Biol. 2012;7:863–870.
   PubMed Web of Science ®Google Scholar
• Rousseau C, Turner OC, Rush E, et al. Sulfolipid deficiency does not affect the virulence of Mycobacterium tuberculosis H37Rv in mice and guinea pigs. Infect Immun. 2003;71:4684–4690.
   PubMedGoogle Scholar
• Rodriguez JE, Ramirez AS, Salas LP, et al. Transcription of genes involved in sulfolipid and polyacyltrehalose biosynthesis of Mycobacterium tuberculosis in experimental latent tuberculosis infection. PLoS ONE. 2013;8:e58378.
   PubMed Web of Science ®Google Scholar
• Morita YS, Fukuda T, Sena CB, et al. Inositol lipid metabolism in mycobacteria: biosynthesis and regulatory mechanisms. Biochim Biophys Acta. 2011;1810:630–641.
   PubMed Web of Science ®Google Scholar
• Gilleron M, Ronet C, Mempel M, et al. Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells. J Biol Chem. 2001;276:34896–34904.
   PubMed Web of Science ®Google Scholar
• Mishra AK, Driessen NN, Appelmelk BJ, et al. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev. 2011;35:1126–1157.
   PubMed Web of Science ®Google Scholar
• Morita YS, Sena CB, Waller RF, et al. PimE is a polyprenol-phosphate-mannose-dependent mannosyltransferase that transfers the fifth mannose of phosphatidylinositol mannoside in mycobacteria. J Biol Chem. 2006;281:25143–25155.
   PubMed Web of Science ®Google Scholar
• Crellin PK, Kovacevic S, Martin KL, et al. Mutations in pimE restore lipoarabinomannan synthesis and growth in a Mycobacterium smegmatis lpqW mutant. J Bacteriol. 2008;190:3690–3699.
   PubMed Web of Science ®Google Scholar
• Eagen WJ, Baumoel LR, Osman SH, et al. Deletion of PimE mannosyltransferase results in increased copper sensitivity in Mycobacterium smegmatis. FEMS Microbiol Lett. 2018;365. DOI:10.1093/femsle/fny025
   PubMed Web of Science ®Google Scholar
• Jozefowski S, Sobota A, Pawlowski A, et al. Mycobacterium tuberculosis lipoarabinomannan enhances LPS-induced TNF-alpha production and inhibits NO secretion by engaging scavenger receptors. Microb Pathog. 2011;50:350–359.
   PubMed Web of Science ®Google Scholar
• Zheng RB, Jegouzo SAF, Joe M, et al. Insights into interactions of mycobacteria with the host innate immune system from a novel array of synthetic mycobacterial glycans. ACS Chem Biol. 2017;12:2990–3002.
   PubMed Web of Science ®Google Scholar
• Li K, Underhill DM. C-type lectin receptors in phagocytosis. Curr Top Microbiol Immunol. 2020;429:1–18.
   PubMed Web of Science ®Google Scholar
• Torrelles JB, Knaup R, Kolareth A, et al. Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. J Biol Chem. 2008;283:31417–31428.
   PubMed Web of Science ®Google Scholar
• Birch HL, Alderwick LJ, Appelmelk BJ, et al. A truncated lipoglycan from mycobacteria with altered immunological properties. Proc Natl Acad Sci U S A. 2010;107:2634–2639.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Kurihara H, Morita YS, et al. Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophils. Sci Signal. 2016;9:ra101.
   PubMed Web of Science ®Google Scholar
• Fratti RA, Chua J, Vergne I, et al. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci U S A. 2003;100:5437–5442.
   PubMed Web of Science ®Google Scholar
• Hawkins PT, Stephens LR, Suire S, et al. PI3K signaling in neutrophils. Curr Top Microbiol Immunol. 2010;346:183–202.
   PubMed Web of Science ®Google Scholar
• Dell’Angelica EC, Mullins C, Caplan S, et al. Lysosome-related organelles. FASEB J. 2000;14:1265–1278.
   PubMed Web of Science ®Google Scholar
• Sani M, Houben EN, Geurtsen J, et al. Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLOS Pathog. 2010;6:e1000794.
   PubMed Web of Science ®Google Scholar
• Angala SK, Belardinelli JM, Huc-Claustre E, et al. The cell envelope glycoconjugates of Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol. 2014;49:361–399.
   PubMed Web of Science ®Google Scholar
• Barnes DD, Lundahl MLE, Lavelle EC, Scanlan, EM, et al. The emergence of phenolic glycans as virulence factors in Mycobacterium tuberculosis. ACS Chem Biol. 2017;12 8 :1969–1979.
   PubMed Web of Science ®Google Scholar
• Rashid AM, Batey SF, Syson K, et al. Assembly of alpha-Glucan by GlgE and GlgB in Mycobacteria and Streptomycetes. Biochemistry. 2016;55:3270–3284.
   PubMed Web of Science ®Google Scholar
• Schwebach JR, Glatman-Freedman A, Gunther-Cummins L, et al. Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo. Infect Immun. 2002;70:2566–2575.
   PubMedGoogle Scholar
• Lemassu A, Daffe M. Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem J. 1994;297(Pt 2):351–357.
   PubMedGoogle Scholar
• Venkataswamy MM, Goldberg MF, Baena A, et al. In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG. Vaccine. 2012;30:1038–1049.
   PubMed Web of Science ®Google Scholar
• Prados-Rosales R, Carreno LJ, Weinrick B, et al. The type of growth medium affects the presence of a mycobacterial capsule and is associated with differences in protective efficacy of BCG vaccination against mycobacterium tuberculosis. J Infect Dis. 2016;214:426–437.
   PubMed Web of Science ®Google Scholar
• Stokes RW, Norris-Jones R, Brooks DE, et al. The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect Immun. 2004;72:5676–5686.
   PubMedGoogle Scholar
• Ortalo-Magne A, Lemassu A, Laneelle MA, et al. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J Bacteriol. 1996;178:456–461.
   PubMed Web of Science ®Google Scholar
• Selvaraj P, Jawahar MS, Rajeswari DN, et al. Role of mannose binding lectin gene variants on its protein levels and macrophage phagocytosis with live Mycobacterium tuberculosis in pulmonary tuberculosis. FEMS Immunol Med Microbiol. 2006;46:433–437.
   PubMedGoogle Scholar
• Yang L, Sinha T, Carlson TK, et al. Changes in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth. Glycobiology. 2013;23:926–934.
   PubMed Web of Science ®Google Scholar
• Gagliardi MC, Lemassu A, Teloni R, et al. Cell wall-associated alpha-glucan is instrumental for Mycobacterium tuberculosis to block CD1 molecule expression and disable the function of dendritic cell derived from infected monocyte. Cell Microbiol. 2007;9:2081–2092.
   PubMed Web of Science ®Google Scholar
• Houben D, Demangel C, van Ingen J, et al. ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol. 2012;14:1287–1298.
   PubMed Web of Science ®Google Scholar
• Wiens KE, Ernst JD. The mechanism for type I interferon induction by mycobacterium tuberculosis is bacterial strain-dependent. PLOS Pathog. 2016;12:e1005809.
   PubMed Web of Science ®Google Scholar
• Zhang L, Jiang X, Pfau D, et al. Type I interferon signaling mediates Mycobacterium tuberculosis-induced macrophage death. J Exp Med. 2021;218. DOI:10.1084/jem.20200887
   Web of Science ®Google Scholar
• Moreira-Teixeira L, Mayer-Barber K, Sher A, et al. Type I interferons in tuberculosis: foe and occasionally friend. J Exp Med. 2018;215:1273–1285.
   PubMed Web of Science ®Google Scholar
• Olson GS, Murray TA, Jahn AN, et al. Type I interferon decreases macrophage energy metabolism during mycobacterial infection. Cell Rep. 2021;35:109195.
   PubMed Web of Science ®Google Scholar
• Deretic V, Levine B. Autophagy balances inflammation in innate immunity. Autophagy. 2018;14:243–251.
   PubMed Web of Science ®Google Scholar
• Gehring AJ, Rojas RE, Canaday DH, et al. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect Immun. 2003;71:4487–4497.
   PubMedGoogle Scholar
• Becker K, Sander P. Mycobacterium tuberculosis lipoproteins in virulence and immunity - fighting with a double-edged sword. FEBS Lett. 2016;590:3800–3819.
   PubMed Web of Science ®Google Scholar
• Palucci I, Camassa S, Cascioferro A, et al. PE_PGRS33 contributes to mycobacterium tuberculosis entry in macrophages through interaction with TLR2. PLoS ONE. 2016;11:e0150800.
   PubMed Web of Science ®Google Scholar
• Basu S, Pathak SK, Banerjee A, et al. Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha. J Biol Chem. 2007;282:1039–1050.
   PubMed Web of Science ®Google Scholar
• Aguilar-Lopez BA, Correa F, Moreno-Altamirano MMB, et al. LprG and PE_PGRS33 Mycobacterium tuberculosis virulence factors induce differential mitochondrial dynamics in macrophages. Scand J Immunol. 2019;89:e12728.
   PubMed Web of Science ®Google Scholar
• Gehring AJ, Dobos KM, Belisle JT, et al. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol. 2004;173:2660–2668.
   PubMed Web of Science ®Google Scholar
• Alonso H, Parra J, Malaga W, et al. Protein O-mannosylation deficiency increases LprG-associated lipoarabinomannan release by Mycobacterium tuberculosis and enhances the TLR2-associated inflammatory response. Sci Rep. 2017;7:7913.
   PubMedGoogle Scholar
• Jung SB, Yang CS, Lee JS, et al. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infect Immun. 2006;74:2686–2696.
   PubMed Web of Science ®Google Scholar
• Byun EH, Kim WS, Kim JS, et al. Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response. FASEB J. 2012;26:2695–2711.
   PubMed Web of Science ®Google Scholar
• Buchko GW, Kim H, Myler PJ, et al. Chemical shift assignments for Rv0577, a putative glyoxalase associated with virulence from Mycobacterium tuberculosis. Biomol NMR Assign. 2012;6:43–46.
   PubMed Web of Science ®Google Scholar
• Huard RC, Chitale S, Leung M, et al. The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. Infect Immun. 2003;71:6871–6883.
   PubMedGoogle Scholar
• Su H, Zhu S, Zhu L, et al. Recombinant lipoprotein Rv1016c derived from mycobacterium tuberculosis is a TLR-2 ligand that induces macrophages apoptosis and inhibits MHC II antigen processing. Front Cell Infect Microbiol. 2016;6:147.
   PubMed Web of Science ®Google Scholar
• Li F, Feng L, Jin C, et al. LpqT improves mycobacteria survival in macrophages by inhibiting TLR2 mediated inflammatory cytokine expression and cell apoptosis. Tuberculosis (Edinb). 2018;111:57–66.
   PubMed Web of Science ®Google Scholar
• Su H, Peng B, Zhang Z, et al. The Mycobacterium tuberculosis glycoprotein Rv1016c protein inhibits dendritic cell maturation, and impairs Th1/Th17 responses during mycobacteria infection. Mol Immunol. 2019;109:58–70.
   PubMed Web of Science ®Google Scholar
• Yeruva VC, Kulkarni A, Khandelwal R, et al. The PE_PGRS proteins of mycobacterium tuberculosis are Ca(2+) binding mediators of host-pathogen interaction. Biochemistry. 2016;55:4675–4687.
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhou Y, Liu S, et al. PE_PGRS: vital proteins in promoting mycobacterial survival and modulating host immunity and metabolism. Cell Microbiol. 2021;23:e13290.
   PubMed Web of Science ®Google Scholar
• Bansal K, Sinha AY, Ghorpade DS, et al. Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses. J Biol Chem. 2010;285:36511–36522.
   PubMed Web of Science ®Google Scholar
• Su H, Kong C, Zhu L, et al. PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response. Oncotarget. 2015;6:38517–38537.
   PubMedGoogle Scholar
• Mi Y, Bao L, Gu D, et al. Mycobacterium tuberculosis PPE25 and PPE26 proteins expressed in Mycobacterium smegmatis modulate cytokine secretion in mouse macrophages and enhance mycobacterial survival. Res Microbiol. 2017;168:234–243.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yang E, Huang Q, et al. PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2. J Mol Med (Berl). 2015;93:645–662.
   PubMed Web of Science ®Google Scholar
• Su H, Zhang Z, Liu Z, et al. Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2-dependent maturation of dendritic cells. J Biol Chem. 2018;293:10287–10302.
   PubMed Web of Science ®Google Scholar
• Gong Z, Kuang Z, Li H, et al. Regulation of host cell pyroptosis and cytokines production by Mycobacterium tuberculosis effector PPE60 requires LUBAC mediated NF-kappaB signaling. Cell Immunol. 2019;335:41–50.
   PubMed Web of Science ®Google Scholar
• Bansal K, Elluru SR, Narayana Y, et al. PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J Immunol. 2010;184:3495–3504.
   PubMed Web of Science ®Google Scholar
• Chaturvedi R, Bansal K, Narayana Y, et al. The multifunctional PE_PGRS11 protein from Mycobacterium tuberculosis plays a role in regulating resistance to oxidative stress. J Biol Chem. 2010;285:30389–30403.
   PubMed Web of Science ®Google Scholar
• Qiang L, Wang J, Zhang Y, et al. Mycobacterium tuberculosis Mce2E suppresses the macrophage innate immune response and promotes epithelial cell proliferation. Cell Mol Immunol. 2019;16:380–391.
   PubMed Web of Science ®Google Scholar
• Li J, Chai QY, Zhang Y, et al. Mycobacterium tuberculosis Mce3E suppresses host innate immune responses by targeting ERK1/2 signaling. J Immunol. 2015;194:3756–3767.
   PubMed Web of Science ®Google Scholar
• Zhang F, Xie JP. Mammalian cell entry gene family of Mycobacterium tuberculosis. Mol Cell Biochem. 2011;352:1–10.
   PubMed Web of Science ®Google Scholar
• Pasricha R, Saini NK, Rathor N, et al. The Mycobacterium tuberculosis recombinant LprN protein of mce4 operon induces Th-1 type response deleterious to protection in mice. Pathog Dis. 2014;72:188–196.
   PubMed Web of Science ®Google Scholar
• Tufariello JM, Mi K, Xu J, et al. Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. Infect Immun. 2006;74:2985–2995.
   PubMed Web of Science ®Google Scholar
• Kim J-S, Kim WS, Choi H-G, et al. Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells. J Leukocyte Biol. 2013;94(4):733–749. DOI:10.1189/jlb.0912435
   PubMed Web of Science ®Google Scholar
• Sakthi S, Narayanan S. The lpqS knockout mutant of Mycobacterium tuberculosis is attenuated in macrophages. Microbiol Res. 2013;168:407–414.
   PubMedGoogle Scholar
• Sala C, Odermatt NT, Soler-Arnedo P, et al. EspL is essential for virulence and stabilizes EspE, EspF and EspH levels in Mycobacterium tuberculosis. PLOS Pathog. 2018;14:e1007491.
   PubMed Web of Science ®Google Scholar
• Sha S, Shi X, Deng G, et al. Mycobacterium tuberculosis Rv1987 induces Th2 immune responses and enhances Mycobacterium smegmatis survival in mice. Microbiol Res. 2017;197:74–80.
   PubMedGoogle Scholar
• Sha S, Shi Y, Tang Y, et al. Mycobacterium tuberculosis Rv1987 protein induces M2 polarization of macrophages through activating the PI3K/Akt1/mTOR signaling pathway. Immunol Cell Biol. 2021;99:570–585.
   PubMed Web of Science ®Google Scholar
• Kim WS, Kim JS, Cha SB, et al. Mycobacterium tuberculosis PE27 activates dendritic cells and contributes to Th1-polarized memory immune responses during in vivo infection. Immunobiology. 2016;221:440–453.
   PubMed Web of Science ®Google Scholar
• Jiao J, Zheng N, Wei W, et al. M. tuberculosis CRISPR/Cas proteins are secreted virulence factors that trigger cellular immune responses. Virulence. 2021;12:3032–3044.
   PubMed Web of Science ®Google Scholar
• Yang F, Xu L, Liang L, et al. The involvement of mycobacterium type III-A CRISPR-Cas system in oxidative stress. Front Microbiol. 2021;12:774492.
   PubMed Web of Science ®Google Scholar
• Madan-Lala R, Sia JK, King R, et al. Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1. J Immunol. 2014;192:4263–4272.
   PubMed Web of Science ®Google Scholar
• Rengarajan J, Murphy E, Park A, et al. Mycobacterium tuberculosis Rv2224c modulates innate immune responses. Proc Natl Acad Sci U S A. 2008;105:264–269.
   PubMed Web of Science ®Google Scholar
• Madan-Lala R, Peixoto KV, Re F, et al. Mycobacterium tuberculosis Hip1 dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation. Infect Immun. 2011;79:4828–4838.
   PubMed Web of Science ®Google Scholar
• Saleh MT, Belisle JT. Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases. J Bacteriol. 2000;182:6850–6853.
   PubMed Web of Science ®Google Scholar
• Vergne I, Chua J, Lee HH, et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2005;102:4033–4038.
   PubMed Web of Science ®Google Scholar
• Puri RV, Reddy PV, Tyagi AK. Secreted acid phosphatase (SapM) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in guinea pig tissues. PLoS ONE. 2013;8:e70514.
   PubMed Web of Science ®Google Scholar
• Zulauf KE, Sullivan JT, Braunstein M. The SecA2 pathway of Mycobacterium tuberculosis exports effectors that work in concert to arrest phagosome and autophagosome maturation. PLOS Pathog. 2018;14:e1007011.
   PubMed Web of Science ®Google Scholar
• Bao Y, Wang L, Sun J. A small protein but with diverse roles: a review of EsxA in mycobacterium–host interaction. Cells. 2021;10:10.
   Web of Science ®Google Scholar
• Zhang Q, Wang D, Jiang G, et al. EsxA membrane-permeabilizing activity plays a key role in mycobacterial cytosolic translocation and virulence: effects of single-residue mutations at glutamine 5. Sci Rep. 2016;6:32618.
   PubMed Web of Science ®Google Scholar
• Iantomasi R, Sali M, Cascioferro A, et al. PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis. Cell Microbiol. 2012;14:356–367.
   PubMed Web of Science ®Google Scholar
• Chatrath S, Gupta VK, Dixit A, et al. PE_PGRS30 of Mycobacterium tuberculosis mediates suppression of proinflammatory immune response in macrophages through its PGRS and PE domains. Microbes Infect. 2016;18:536–542.
   PubMed Web of Science ®Google Scholar
• Sullivan JT, Young EF, McCann JR, et al. The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages. Infect Immun. 2012;80:996–1006.
   PubMed Web of Science ®Google Scholar
• Wong D, Bach H, Sun J, et al. Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolar-H±ATPase to inhibit phagosome acidification. Proc Natl Acad Sci U S A. 2011;108:19371–19376.
   PubMed Web of Science ®Google Scholar
• Wang J, Li BX, Ge PP, et al. Mycobacterium tuberculosis suppresses innate immunity by coopting the host ubiquitin system. Nat Immunol. 2015;16:237–245.
   PubMed Web of Science ®Google Scholar
• Bach H, Papavinasasundaram KG, Wong D, et al. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe. 2008;3:316–322.
   PubMed Web of Science ®Google Scholar
• Pradhan G, Shrivastva R, Mukhopadhyay S. Mycobacterial PknG targets the Rab7l1 signaling pathway to inhibit phagosome-lysosome fusion. J Immunol. 2018;201:1421–1433.
   PubMed Web of Science ®Google Scholar
• Wang J, Ge P, Lei Z, et al. Mycobacterium tuberculosis protein kinase G acts as an unusual ubiquitinating enzyme to impair host immunity. EMBO Rep. 2021;22:e52175.
   PubMed Web of Science ®Google Scholar
• Ge P, Lei Z, Yu Y, et al. M. tuberculosis PknG manipulates host autophagy flux to promote pathogen intracellular survival. Autophagy. 2021;18(3):576-594. doi:10.1080/15548627.2021.1938912.
   Web of Science ®Google Scholar
• Sannigrahi A, Nandi I, Chall S, et al. Conformational switch driven membrane pore formation by mycobacterium secretory protein MPT63 induces macrophage cell death. ACS Chem Biol. 2019;14:1601–1610.
   PubMed Web of Science ®Google Scholar
• Siromolot AA, Oliinyk OS, Kolibo DV, et al. Mycobacterium tuberculosis antigens MPT63 and MPT83 increase phagocytic activity of murine peritoneal macrophages. Ukr Biochem J. 2016;88:62–70.
   PubMedGoogle Scholar
• Thi EP, Hong CJ, Sanghera G, et al. Identification of the Mycobacterium tuberculosis protein PE-PGRS62 as a novel effector that functions to block phagosome maturation and inhibit iNOS expression. Cell Microbiol. 2013;15:795–808.
   PubMed Web of Science ®Google Scholar
• Long Q, Xiang X, Yin Q, et al. PE_PGRS62 promotes the survival of Mycobacterium smegmatis within macrophages via disrupting ER stress-mediated apoptosis. J Cell Physiol. 2019;234:19774–19784.
   PubMed Web of Science ®Google Scholar
• Mittal E, Kumar S, Rahman A, et al. Modulation of phagolysosome maturation by bacterial tlyA gene product. J Biosci. 2014;39:821–834.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Sobia P, Dwivedi VP, et al. Mycobacterium tuberculosis TlyA protein negatively regulates T helper (Th) 1 and Th17 differentiation and promotes tuberculosis pathogenesis. J Biol Chem. 2015;290:14407–14417.
   PubMed Web of Science ®Google Scholar
• Deghmane AE, Soualhine H, Bach H, et al. Lipoamide dehydrogenase mediates retention of coronin-1 on BCG vacuoles, leading to arrest in phagosome maturation. J Cell Sci. 2007;120:2796–2806.
   PubMed Web of Science ®Google Scholar
• Heo DR, Shin SJ, Kim WS, et al. Mycobacterium tuberculosislpdC, Rv0462, induces dendritic cell maturation and Th1 polarization. Biochem Biophys Res Commun. 2011;411:642–647.
   PubMed Web of Science ®Google Scholar
• Sun J, Wang X, Lau A, et al. Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS ONE. 2010;5:e8769.
   PubMed Web of Science ®Google Scholar
• Cui Z, Dang G, Song N, et al. Rv3091, an extracellular patatin-like phospholipase in mycobacterium tuberculosis, prolongs intracellular survival of recombinant mycolicibacterium smegmatis by mediating phagosomal escape. Front Microbiol. 2020;11:2204.
   PubMed Web of Science ®Google Scholar
• Mehra A, Zahra A, Thompson V, et al. Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking. PLOS Pathog. 2013;9:e1003734.
   PubMed Web of Science ®Google Scholar
• Shin DM, Jeon BY, Lee HM, et al. Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redox-dependent signaling. PLOS Pathog. 2010;6:e1001230.
   PubMed Web of Science ®Google Scholar
• Duan L, Yi M, Chen J, et al. Mycobacterium tuberculosis EIS gene inhibits macrophage autophagy through up-regulation of IL-10 by increasing the acetylation of histone H3. Biochem Biophys Res Commun. 2016;473:1229–1234.
   PubMed Web of Science ®Google Scholar
• Kim KH, An DR, Song J, et al. Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc Natl Acad Sci U S A. 2012;109:7729–7734.
   PubMed Web of Science ®Google Scholar
• Huang D, Bao L. Mycobacterium tuberculosis EspB protein suppresses interferon-gamma-induced autophagy in murine macrophages. J Microbiol Immunol Infect. 2016;49:859–865.
   PubMedGoogle Scholar
• Choi JA, Lim YJ, Cho SN, et al. Mycobacterial HBHA induces endoplasmic reticulum stress-mediated apoptosis through the generation of reactive oxygen species and cytosolic Ca2+ in murine macrophage RAW 264.7 cells. Cell Death Dis. 2013;4:e957.
   PubMed Web of Science ®Google Scholar
• Lanfranconi MP, Arabolaza A, Gramajo H, et al. Insights into the evolutionary history of the virulent factor HBHA of Mycobacterium tuberculosis. Arch Microbiol. 2021;203:2171–2182.
   PubMed Web of Science ®Google Scholar
• Menozzi FD, Rouse JH, Alavi M, et al. Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med. 1996;184:993–1001.
   PubMed Web of Science ®Google Scholar
• Pethe K, Alonso S, Biet F, et al. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature. 2001;412:190–194.
   PubMed Web of Science ®Google Scholar
• Guo Q, Bi J, Wang H, et al. Mycobacterium tuberculosis ESX-1-secreted substrate protein EspC promotes mycobacterial survival through endoplasmic reticulum stress-mediated apoptosis. Emerg Microbes Infect. 2021;10:19–36.
   PubMed Web of Science ®Google Scholar
• Velmurugan K, Chen B, Miller JL, et al. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLOS Pathog. 2007;3:e110.
   PubMed Web of Science ®Google Scholar
• Blomgran R, Desvignes L, Briken V, et al. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe. 2012;11:81–90.
   PubMed Web of Science ®Google Scholar
• Danelishvili L, Yamazaki Y, Selker J, et al. Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis. PLoS ONE. 2010;5:e10474.
   PubMed Web of Science ®Google Scholar
• Kumar D, Narayanan S. pknE, a serine/threonine kinase of Mycobacterium tuberculosis modulates multiple apoptotic paradigms. Infect Genet Evol. 2012;12:737–747.
   PubMed Web of Science ®Google Scholar
• Jayakumar D, Jacobs WR Jr., Narayanan S. Protein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection. Cell Microbiol. 2008;10:365–374.
   PubMed Web of Science ®Google Scholar
• Zhang W, Lu Q, Dong Y, et al. Rv3033, as an emerging anti-apoptosis factor, facilitates mycobacteria survival via inhibiting macrophage intrinsic apoptosis. Front Immunol. 2018;9:2136.
   PubMed Web of Science ®Google Scholar
• Sun J, Siroy A, Lokareddy RK, et al. The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD. Nat Struct Mol Biol. 2015;22:672–678.
   PubMed Web of Science ®Google Scholar
• Danilchanka O, Sun J, Pavlenok M, et al. An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity. Proc Natl Acad Sci U S A. 2014;111:6750–6755.
   PubMed Web of Science ®Google Scholar
• Chen W, Bao Y, Chen X, et al. Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses. Med Microbiol Immunol. 2016;205:119–131.
   PubMed Web of Science ®Google Scholar
• Singh P, Rao RN, Reddy JR, et al. PE11, a PE/PPE family protein of Mycobacterium tuberculosis is involved in cell wall remodeling and virulence. Sci Rep. 2016;6:21624.
   PubMedGoogle Scholar
• Rastogi S, Singh AK, Pant G, et al. Down-regulation of PE11, a cell wall associated esterase, enhances the biofilm growth of Mycobacterium tuberculosis and reduces cell wall virulence lipid levels. Microbiology (Reading). 2017;163:52–61.
   PubMed Web of Science ®Google Scholar
• Deng W, Zeng J, Xiang X, et al. PE11 (Rv1169c) selectively alters fatty acid components of Mycobacterium smegmatis and host cell interleukin-6 level accompanied with cell death. Front Microbiol. 2015;6:613.
   PubMed Web of Science ®Google Scholar
• Master SS, Rampini SK, Davis AS, et al. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe. 2008;3:224–232.
   PubMed Web of Science ®Google Scholar
• Vemula MH, Medisetti R, Ganji R, et al. Mycobacterium tuberculosis zinc metalloprotease-1 assists mycobacterial dissemination in zebrafish. Front Microbiol. 2016;7:1347.
   PubMed Web of Science ®Google Scholar
• Danelishvili L, Everman JL, McNamara MJ, et al. Inhibition of the plasma-membrane-associated serine protease Cathepsin G by mycobacterium tuberculosis Rv3364c suppresses Caspase-1 and pyroptosis in macrophages. Front Microbiol. 2011;2:281.
   PubMedGoogle Scholar
• Rastogi S, Ellinwood S, Augenstreich J, et al. Mycobacterium tuberculosis inhibits the NLRP3 inflammasome activation via its phosphokinase PknF. PLOS Pathog. 2021;17:e1009712.
   PubMed Web of Science ®Google Scholar
• Sethi D, Mahajan S, Singh C, et al. Lipoprotein LprI of mycobacterium tuberculosis acts as a lysozyme inhibitor. J Biol Chem. 2016;291:2938–2953.
   PubMed Web of Science ®Google Scholar
• Vazquez Reyes S, Ray S, Aguilera J, et al. Development of an in vitro membrane model to study the function of EsxAB Heterodimer and establish the role of EsxB in membrane permeabilizing activity of mycobacterium tuberculosis. Pathogens. 2020;9:1015.
   PubMed Web of Science ®Google Scholar
• Welin A, Bjornsdottir H, Winther M, et al. CFP-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor. Infect Immun. 2015;83:205–213.
   PubMed Web of Science ®Google Scholar
• Mubin N, Pahari S, Owais M, et al. Mycobacterium tuberculosis host cell interaction: role of latency associated protein Acr-1 in differential modulation of macrophages. PLoS ONE. 2018;13:e0206459.
   PubMed Web of Science ®Google Scholar
• Siddiqui KF, Amir M, Gurram RK, et al. Latency-associated protein Acr1 impairs dendritic cell maturation and functionality: a possible mechanism of immune evasion by Mycobacterium tuberculosis. J Infect Dis. 2014;209:1436–1445.
   PubMed Web of Science ®Google Scholar
• Beaulieu AM, Rath P, Imhof M, et al. Genome-wide screen for Mycobacterium tuberculosis genes that regulate host immunity. PLoS ONE. 2010;5:e15120.
   PubMed Web of Science ®Google Scholar
• Deng G, Zhang F, Yang S, et al. Mycobacterium tuberculosis Rv0431 expressed in Mycobacterium smegmatis, a potentially mannosylated protein, mediated the immune evasion of RAW 264.7 macrophages. Microb Pathog. 2016;100:285–292.
   PubMed Web of Science ®Google Scholar
• Rath P, Huang C, Wang T, et al. Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2013;110:E4790–7.
   PubMed Web of Science ®Google Scholar
• Georgieva M, Sia JK, Bizzell E, et al. Mycobacterium tuberculosis GroEL2 modulates dendritic cell responses. Infect Immun. 2018;86. DOI:10.1128/IAI.00387-17
   PubMed Web of Science ®Google Scholar
• Li H, Dang G, Liu H, et al. Characterization of a novel Mycobacterium tuberculosis serine protease (Rv3194c) activity and pathogenicity. Tuberculosis (Edinb). 2019;119:101880.
   PubMed Web of Science ®Google Scholar
• Stamm CE, Pasko BL, Chaisavaneeyakorn S, et al. Screening mycobacterium tuberculosis secreted proteins identifies Mpt64 as a eukaryotic membrane-binding bacterial effector. mSphere. 2019;4. DOI:10.1128/mSphere.00354-19.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu S, Tang Y, et al. MPT64 protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-kB-miRNA21-Bcl-2 pathway. PLoS ONE. 2014;9:e100949.
   PubMedGoogle Scholar
• Sharma K, Gupta M, Pathak M, et al. Transcriptional control of the mycobacterial embCAB operon by PknH through a regulatory protein, EmbR, in vivo. J Bacteriol. 2006;188:2936–2944.
   PubMed Web of Science ®Google Scholar
• Mata E, Farrell D, Ma R, et al. Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preference. PLOS Pathog. 2020;16:e1009061.
   PubMed Web of Science ®Google Scholar
• Na I, Dai H, Li H, et al. Computational prediction and validation of specific EmbR binding site on PknH. Synth Syst Biotechnol. 2021;6:429–436.
   PubMed Web of Science ®Google Scholar
• Shariq M, Quadir N, Sharma N, et al. Mycobacterium tuberculosis RipA Dampens TLR4-mediated host protective response using a multi-pronged approach involving autophagy, apoptosis, metabolic repurposing, and immune modulation. Front Immunol. 2021;12:636644.
   PubMedGoogle Scholar
• Gallant J, Heunis T, Beltran C, et al. PPE38-secretion-dependent proteins of M. tuberculosis alter NF-kB signalling and inflammatory responses in macrophages. Front Immunol. 2021;12:702359.
   PubMed Web of Science ®Google Scholar
• Ates LS, Dippenaar A, Ummels R, et al. Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosis. Nat Microbiol. 2018;3:181–188.
   PubMed Web of Science ®Google Scholar
• Stamm CE, Collins AC, Shiloh MU. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus. Immunol Rev. 2015;264:204–219.
   PubMed Web of Science ®Google Scholar
• Basu J, Shin DM, Jo EK. Mycobacterial signaling through toll-like receptors. Front Cell Infect Microbiol. 2012;2:145.
   PubMed Web of Science ®Google Scholar
• Yu X, Zeng J, Xie J. Navigating through the maze of TLR2 mediated signaling network for better mycobacterium infection control. Biochimie. 2014;102:1–8.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511.
   PubMed Web of Science ®Google Scholar
• Underhill DM, Ozinsky A, Smith KD, et al. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A. 1999;96:14459–14463.
   PubMed Web of Science ®Google Scholar
• Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 2009;388:621–625.
   PubMed Web of Science ®Google Scholar
• Songane M, Kleinnijenhuis J, Netea MG, et al. The role of autophagy in host defence against Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2012;92:388–396.
   PubMed Web of Science ®Google Scholar
• Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537–544.
   PubMed Web of Science ®Google Scholar
• Zumbo A, Palucci I, Cascioferro A, et al. Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 of Mycobacterium tuberculosis. Pathog Dis. 2013;69:232–239.
   PubMed Web of Science ®Google Scholar
• Post FA, Manca C, Neyrolles O, et al. Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun. 2001;69:1433–1439.
   PubMed Web of Science ®Google Scholar
• Hinman AE, Jani C, Pringle SC, et al. Mycobacterium tuberculosis canonical virulence factors interfere with a late component of the TLR2 response. Elife. 2021;10. DOI:10.7554/eLife.73984.
   Web of Science ®Google Scholar
• Zhang Y, Li J, Li B, et al. Mycobacterium tuberculosis Mce3C promotes mycobacteria entry into macrophages through activation of β2 integrin-mediated signalling pathway. Cell Microbiol. 2018;20:20.
   Web of Science ®Google Scholar
• Ahmad S, El-Shazly S, Mustafa AS, et al. The six mammalian cell entry proteins (Mce3a-F) encoded by the mce3 operon are expressed during in vitro growth of Mycobacterium tuberculosis. Scand J Immunol. 2005;62:16–24.
   PubMed Web of Science ®Google Scholar
• Ahmad S, El-Shazly S, Mustafa AS, et al. Mammalian cell-entry proteins encoded by the mce3 operon of Mycobacterium tuberculosis are expressed during natural infection in humans. Scand J Immunol. 2004;60:382–391.
   PubMed Web of Science ®Google Scholar
• Xia A, Li X, Quan J, et al. Mycobacterium tuberculosis Rv0927c inhibits NF-kappaB pathway by downregulating the phosphorylation level of IkappaBalpha and enhances mycobacterial survival. Front Immunol. 2021;12:721370.
   PubMed Web of Science ®Google Scholar
• Khan MZ, Nandicoori VK. Deletion of pknG abates reactivation of latent mycobacterium tuberculosis in mice. Antimicrob Agents Chemother. 2021;65. DOI:10.1128/AAC.02095-20
   Web of Science ®Google Scholar
• Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol. 2007;8:917–929.
   PubMed Web of Science ®Google Scholar
• Hackam DJ, Rotstein OD, Zhang WJ, et al. Regulation of phagosomal acidification. Differential targeting of Na+/H+ exchangers, Na+/K±ATPases, and vacuolar-type H±atpases. J Biol Chem. 1997;272:29810–29820.
   PubMed Web of Science ®Google Scholar
• Zhou P, Li W, Wong D, et al. Phosphorylation control of protein tyrosine phosphatase a activity in Mycobacterium tuberculosis. FEBS Lett. 2015;589:326–331.
   PubMed Web of Science ®Google Scholar
• Wang J, Ge P, Qiang L, et al. The mycobacterial phosphatase PtpA regulates the expression of host genes and promotes cell proliferation. Nat Commun. 2017;8:244.
   PubMed Web of Science ®Google Scholar
• Poirier V, Bach H, Av-Gay Y. Mycobacterium tuberculosis promotes anti-apoptotic activity of the macrophage by PtpA protein-dependent dephosphorylation of host GSK3alpha. J Biol Chem. 2014;289:29376–29385.
   PubMed Web of Science ®Google Scholar
• Mittal E, Skowyra ML, Uwase G, et al. Mycobacterium tuberculosis type VII secretion system effectors differentially impact the ESCRT endomembrane damage response. MBio. 2018;9. DOI:10.1128/mBio.01765-18.
   PubMed Web of Science ®Google Scholar
• Jayachandran R, Sundaramurthy V, Combaluzier B, et al. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell. 2007;130:37–50.
   PubMed Web of Science ®Google Scholar
• van der Wel N, Hava D, Houben D, et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell. 2007;129:1287–1298.
   PubMed Web of Science ®Google Scholar
• Simeone R, Bobard A, Lippmann J, et al. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLOS Pathog. 2012;8:e1002507.
   PubMed Web of Science ®Google Scholar
• Kinhikar AG, Verma I, Chandra D, et al. Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells. Mol Microbiol. 2010;75:92–106.
   PubMed Web of Science ®Google Scholar
• Sreejit G, Ahmed A, Parveen N, et al. The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (beta2m) affecting antigen presentation function of macrophage. PLOS Pathog. 2014;10:e1004446.
   PubMed Web of Science ®Google Scholar
• Pathak SK, Basu S, Basu KK, et al. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol. 2007;8:610–618.
   PubMed Web of Science ®Google Scholar
• Hsu T, Hingley-Wilson SM, Chen B, et al. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A. 2003;100:12420–12425.
   PubMed Web of Science ®Google Scholar
• Stanley SA, Johndrow JE, Manzanillo P, et al. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J Immunol. 2007;178:3143–3152.
   PubMed Web of Science ®Google Scholar
• de Jonge MI, Pehau-Arnaudet G, Fretz MM, et al. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol. 2007;189:6028–6034.
   PubMed Web of Science ®Google Scholar
• Aguilera J, Karki CB, Li L, et al. N (alpha)-Acetylation of the virulence factor EsxA is required for mycobacterial cytosolic translocation and virulence. J Biol Chem. 2020;295:5785–5794.
   PubMed Web of Science ®Google Scholar
• Augenstreich J, Haanappel E, Sayes F, et al. Phthiocerol Dimycocerosates from mycobacterium tuberculosis increase the membrane activity of bacterial effectors and host receptors. Front Cell Infect Microbiol. 2020;10:420.
   PubMedGoogle Scholar
• Osman MM, Shanahan JK, Chu F, et al. The C terminus of the mycobacterium ESX-1 secretion system substrate ESAT-6 is required for phagosomal membrane damage and virulence. Proc Natl Acad Sci U S A. 2022;119:e2122161119.
   PubMed Web of Science ®Google Scholar
• Rahman MS, Ammerman NC, Sears KT, et al. Functional characterization of a phospholipase A(2) homolog from Rickettsia typhi. J Bacteriol. 2010;192:3294–3303.
   PubMed Web of Science ®Google Scholar
• Rahman MS, Gillespie JJ, Kaur SJ, et al. Rickettsia typhi possesses phospholipase A2 enzymes that are involved in infection of host cells. PLOS Pathog. 2013;9:e1003399.
   PubMed Web of Science ®Google Scholar
• Ku B, Lee KH, Park WS, et al. VipD of Legionella pneumophila targets activated Rab5 and Rab22 to interfere with endosomal trafficking in macrophages. PLOS Pathog. 2012;8:e1003082.
   PubMed Web of Science ®Google Scholar
• Gaspar AH, Machner MP. VipD is a Rab5-activated phospholipase A1 that protects Legionella pneumophila from endosomal fusion. Proc Natl Acad Sci U S A. 2014;111:4560–4565.
   PubMed Web of Science ®Google Scholar
• Shariq M, Quadir N, Alam A, et al. The exploitation of host autophagy and ubiquitin machinery by Mycobacterium tuberculosis in shaping immune responses and host defense during infection. Autophagy. 2022;1–21. DOI:10.1080/15548627.2021.2021495.
   Web of Science ®Google Scholar
• Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119:753–766.
   PubMed Web of Science ®Google Scholar
• Mahairas GG, Sabo PJ, Hickey MJ, et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996;178:1274–1282.
   PubMed Web of Science ®Google Scholar
• Manzanillo PS, Ayres JS, Watson RO, et al. The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature. 2013;501:512–516.
   PubMed Web of Science ®Google Scholar
• Franco LH, Nair VR, Scharn CR, et al. The ubiquitin ligase Smurf1 functions in selective autophagy of mycobacterium tuberculosis and anti-tuberculous host defense. Cell Host Microbe. 2017;22:421–423.
   PubMed Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469:323–335.
   PubMed Web of Science ®Google Scholar
• Chai Q, Wang X, Qiang L, et al. A Mycobacterium tuberculosis surface protein recruits ubiquitin to trigger host xenophagy. Nat Commun. 2019;10:1973.
   PubMed Web of Science ®Google Scholar
• Hu D, Wu J, Wang W, et al. Autophagy regulation revealed by SapM-induced block of autophagosome-lysosome fusion via binding RAB7. Biochem Biophys Res Commun. 2015;461:401–407.
   PubMed Web of Science ®Google Scholar
• Behar SM, Briken V. Apoptosis inhibition by intracellular bacteria and its consequence on host immunity. Curr Opin Immunol. 2019;60:103–110.
   PubMed Web of Science ®Google Scholar
• Schaible UE, Winau F, Sieling PA, et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med. 2003;9:1039–1046.
   PubMed Web of Science ®Google Scholar
• Sun J, Singh V, Lau A, et al. Mycobacterium tuberculosis nucleoside diphosphate kinase inactivates small GTPases leading to evasion of innate immunity. PLOS Pathog. 2013;9:e1003499.
   PubMed Web of Science ®Google Scholar
• Miller JL, Velmurugan K, Cowan MJ, et al. The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-alpha-mediated host cell apoptosis. PLOS Pathog. 2010;6:e1000864.
   PubMed Web of Science ®Google Scholar
• Boise LH, Collins CM. Salmonella-induced cell death: apoptosis, necrosis or programmed cell death? Trends Microbiol. 2001;9:64–67.
   PubMed Web of Science ®Google Scholar
• Rastogi S, Briken V. Interaction of mycobacteria with host cell inflammasomes. Front Immunol. 2022;13:791136.
   PubMed Web of Science ®Google Scholar
• Wong KW, Jacobs WR Jr. Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis. Cell Microbiol. 2011;13:1371–1384.
   PubMed Web of Science ®Google Scholar
• Kurane T, Matsunaga T, Ida T, et al. GRIM-19 is a target of mycobacterial Zn(2+) metalloprotease 1 and indispensable for NLRP3 inflammasome activation. FASEB J. 2022;36:e22096.
   PubMed Web of Science ®Google Scholar
• Beckwith KS, Beckwith MS, Ullmann S, et al. Plasma membrane damage causes NLRP3 activation and pyroptosis during Mycobacterium tuberculosis infection. Nat Commun. 2020;11:2270.
   PubMed Web of Science ®Google Scholar
• Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol. 2010;8:668–674.
   PubMed Web of Science ®Google Scholar
• Srinivasan L, Ahlbrand S, Briken V. Interaction of Mycobacterium tuberculosis with host cell death pathways. Cold Spring Harb Perspect Med. 2014;4:a022459.
   PubMed Web of Science ®Google Scholar
• Pajuelo D, Tak U, Zhang L, et al. Toxin secretion and trafficking by Mycobacterium tuberculosis. Nat Commun. 2021;12:6592.
   PubMed Web of Science ®Google Scholar
• Izquierdo Lafuente B, Ummels R, Kuijl C, et al. Mycobacterium tuberculosis Toxin CpnT is an ESX-5 substrate and requires three type VII secretion systems for intracellular secretion. MBio. 2021;12. DOI:10.1128/mBio.02983-20
   PubMed Web of Science ®Google Scholar
• Pajuelo D, Gonzalez-Juarbe N, Tak U, et al. NAD(+) depletion triggers macrophage necroptosis, a cell death pathway exploited by mycobacterium tuberculosis. Cell Rep. 2018;24:429–440.
   PubMed Web of Science ®Google Scholar
• Tundup S, Mohareer K, Hasnain SE. Mycobacterium tuberculosis PE25/PPE41 protein complex induces necrosis in macrophages: role in virulence and disease reactivation? FEBS Open Bio. 2014;4:822–828.
   PubMed Web of Science ®Google Scholar
• Amaral EP, Costa DL, Namasivayam S, et al. A major role for ferroptosis in Mycobacterium tuberculosis-induced cell death and tissue necrosis. J Exp Med. 2019;216:556–570.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The end TB strategy. 2015.
   Google Scholar
• Cobelens F, Suri RK, Helinski M, et al. Accelerating research and development of new vaccines against tuberculosis: a global roadmap. Lancet Infect Dis. 2022;22:e108–20.
   PubMed Web of Science ®Google Scholar
• Bendre AD, Peters PJ, Kumar J. Tuberculosis: past, present and future of the treatment and drug discovery research. Curr Res Pharmacol Drug Discov. 2021;2:100037.
   PubMedGoogle Scholar
• Tait DR, Hatherill M, Van Der Meeren O, et al. Final analysis of a trial of M72/AS01E vaccine to prevent tuberculosis. N Engl J Med. 2019;381:2429–2439.
   PubMed Web of Science ®Google Scholar
• Arbues A, Aguilo JI, Gonzalo-Asensio J, et al. Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials. Vaccine. 2013;31:4867–4873.
   PubMed Web of Science ®Google Scholar
• Gonzalo-Asensio J, Marinova D, Martin C, et al. MTBVAC: attenuating the human pathogen of tuberculosis (TB) toward a promising vaccine against the TB epidemic. Front Immunol. 2017;8:1803.
   PubMed Web of Science ®Google Scholar
• White AD, Sibley L, Sarfas C, et al. MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies. NPJ Vaccines. 2021;6:4.
   PubMed Web of Science ®Google Scholar
• Martin C, Marinova D, Aguilo N, et al. MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG. Vaccine. 2021;39:7277–7285.
   PubMed Web of Science ®Google Scholar
• BioNTech. BioNtech provides update on plans to develop sustainable solutions to address infectious diseases on the African continent. 2021.
   Google Scholar
• World Health Organization. Rapid communication: tB antigen-based skin tests for the diagnosis of TB infection. (WHO/UCN/TB/2022.1). 2022.
   Google Scholar
• Villar-Hernandez R, Blauenfeldt T, Garcia-Garcia E, et al. Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination. Sci Rep. 2020;10:13234.
   PubMed Web of Science ®Google Scholar
• Kamariza M, Keyser SGL, Utz A, et al. Toward point-of-care detection of mycobacterium tuberculosis: a brighter solvatochromic probe detects mycobacteria within minutes. JACS Au. 2021;1:1368–1379.
   PubMedGoogle Scholar
• Rundell SR, Wagar ZL, Meints LM, et al. Deoxyfluoro-d-trehalose (FDTre) analogues as potential PET probes for imaging mycobacterial infection. Org Biomol Chem. 2016;14:8598–8609.
   PubMed Web of Science ®Google Scholar
• Ordonez AA, Sellmyer MA, Gowrishankar G, et al. Molecular imaging of bacterial infections: overcoming the barriers to clinical translation. Sci Transl Med. 2019;11:11.
   Web of Science ®Google Scholar
• Gomez GB, Siapka M, Conradie F, et al. Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines. BMJ Open. 2021;11:e051521.
   PubMed Web of Science ®Google Scholar
• Huszar S, Chibale K, Singh V. The quest for the holy grail: new antitubercular chemical entities, targets and strategies. Drug Discov Today. 2020;25:772–780.
   PubMed Web of Science ®Google Scholar
• Modak B, Girkar S, Narayan R, et al. Mycobacterial membranes as actionable targets for lipid-centric therapy in tuberculosis. J Med Chem. 2022;65:3046–3065.
   PubMed Web of Science ®Google Scholar
• Fernandez-Soto P, Casulli J, Solano-Castro D, et al. Discovery of uncompetitive inhibitors of SapM that compromise intracellular survival of Mycobacterium tuberculosis. Sci Rep. 2021;11:7667.
   PubMed Web of Science ®Google Scholar
• Silwal P, Paik S, Kim JK, et al. Regulatory mechanisms of autophagy-targeted antimicrobial therapeutics against mycobacterial infection. Front Cell Infect Microbiol. 2021;11:633360.
   PubMed Web of Science ®Google Scholar
• Rankine-Wilson LI, Shapira T, Sao Emani C, et al. From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis. Microbiology (Reading). 2021;167. DOI:10.1099/mic.0.001041
   PubMed Web of Science ®Google Scholar
• Krug S, Parveen S, Bishai WR. Host-directed therapies: modulating inflammation to treat tuberculosis. Front Immunol. 2021;12:660916.
   PubMed Web of Science ®Google Scholar
• Nathan C. Kunkel lecture: fundamental immunodeficiency and its correction. J Exp Med. 2017;214:2175–2191.
   PubMed Web of Science ®Google Scholar